In cancer-fighting buying spree, Gilead said to eye East Bay biotech

Just across the San Mateo Bridge, Gilead reportedly is weighing a bid for a third Bay Area cancer company.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.